Rigel Pharmaceuticals, Inc. (RIGL)

NMS – Real Time Price. Currency in USD

41.81

-0.21 (-0.51%)

Market open: Aug 12, 2026, 2:05 PM EDT

42.39

+0.37 (0.88%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

294M

179M

117M

120M

Cost of goods sold

-20M

-19M

-7M

-2M

Gross Profit

275M

161M

110M

118M

Operating expenses (excl. COGS)

-149M

-136M

-130M

-173M

Operating Income

125M

24M

-20M

-54M

Non-operating income, total

-4M

-6M

-5M

-4M

Pretax income

122M

18M

-25M

-59M

Equity in earnings

Taxes

245M

-881K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

367M

17M

-25M

-59M

Discontinued operations

Net income

367M

17M

-25M

-59M

Dilution adjustment

Preferred dividends

Rigel Pharmaceuticals, Inc. (RIGL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rigel Pharmaceuticals, Inc. (RIGL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Rigel Pharmaceuticals, Inc. (RIGL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rigel Pharmaceuticals, Inc. (RIGL)

Income Statement (Annual)

Income Statement (Annual)